Scilex Holding Co. (SCLX)
2.82
-0.03
(-1.05%)
USD |
NASDAQ |
Oct 15, 16:00
2.87
+0.05
(+1.77%)
After-Hours: 20:00
Scilex Gross Profit Margin (Quarterly) : 14.73% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.73% |
| March 31, 2026 | 15.06% |
| December 31, 2025 | 12.33% |
| September 30, 2025 | 58.80% |
| June 30, 2025 | 56.73% |
| March 31, 2025 | 52.30% |
| December 31, 2024 | 61.78% |
| September 30, 2024 | 66.93% |
| June 30, 2024 | 67.04% |
| Date | Value |
|---|---|
| March 31, 2024 | 55.25% |
| December 31, 2023 | 58.74% |
| September 30, 2023 | 56.20% |
| June 30, 2023 | 58.57% |
| March 31, 2023 | 56.27% |
| December 31, 2022 | |
| September 30, 2022 | 59.15% |
| June 30, 2022 | 68.66% |
| March 31, 2022 | 69.33% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
| Veru, Inc. | -- |
| Johnson & Johnson | 73.00% |
| Eli Lilly & Co. | 85.78% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -183.1% |
| Profit Margin (Quarterly) | -1.52K% |
| Operating Margin (Quarterly) | -385.0% |
| Return on Net Operating Assets | -334.0% |